Probiotics supplementation has shown to reduce the amount of bile acids – an important component of nutrition – in the gastric residuals of extremely pre-term babies, according to an RCT from Australia.
MGC Pharma is registering a botanical and vitamin supplement that is currently being trialled on COVID-19 patients for sale in Slovenia, while the long-term goal is to launch it as a pharmaceutical product.
The new company, which is led by Dr Rolf Smeets (a former executive of Danone’s medical food division) and Dr Guru Ramanathan (former Chief Innovation Officer for GNC), aims to make its innovative products accessible in underserved markets.
The Association of Southeast Asian Nations (ASEAN) was China’s biggest export destination for dietary supplement ingredients and products in the first half of this year, while the Middle East is likely to offer further growth potential, says a report...
Gamma-aminobutyric acid (GABA), indigestible dextrin, and omega-3 are three of the most commonly used ingredients in Foods with Function Claims (FFCs) in Japan, according to exclusive data revealed in the second of our spotlights on the market.
Taking inulin after an antibiotic therapy could reduce the amount of alanine aminotransferase (ALT) – an enzyme linked to liver damage – in individuals suffering from non-alcoholic fatty liver disease (NAFLD), a study has shown.
See July's 10 most read stories, including new findings on the types of health supplements that could reduce COVID-19 severity, products that consumers in China have been taking during the COVID-19 lockdown, as well as brand stories.
Australian regulator the Therapeutic Goods Administration (TGA) has doubled-down on its stance that online supplements and nutritional adverts intended for health professionals should not be accessible by the public and tools such as username and password...
Blackmores’ practitioner-only health supplement brand BioCeuticals will be replacing the labelling for its botanical-based immunity product ArmaForce, after consumers complained of unknown side-effects such as taste loss.
Australian brand Bioclinic Naturals has launched a range of ‘scobiotics’ – consisting prebiotics, probiotics, yeast, spirulina and enzymes – designed to address gastrointestinal problems ranging from inflammation to bringing homeostasis in the gut microflora.
The total number of Foods for Special Medical Purpose (FSMPs) approved in China has now exceed 50, helping to boost what e-commerce giant JD states in one of the fastest growing nutrition sectors in the country.
The New Zealand natural health products industry’s combined revenue last year was NZD$2.3bn (US$1.4bn), up 64% from five years ago, but the potential of even greater growth has been hampered by regulatory restrictions and low working capital.
A cohort study conducted in China found that females suffering from infertility and polycystic ovary syndrome (PCOS) experienced lower oxidative stress in their bodies and can reduce their hormone medication dosage after a brief period of vitamin E supplementation.
India is in a prime position to become a major player on the global nutraceutical stage, writes Amit Srivastava from the Nutrify India project, which aims to empower responsible nutrition businesses in the country.
A two-week clinical trial led by renowned Chinese pulmonologist Zhong Nanshan has shown that consuming the botanical TCM product Lianhua Qingwen (LH) capsules and undergoing the standard therapy can speed up recovery in COVID-19 patients.
The standard of nutritional clinical research in APAC has improved by “leaps and bounds” in recent years, but researchers still need to take note of pitfalls such as biased judgements because strong science provides the cornerstone of commercially successful...
Foods for Special Medical Purposes (FSMPs), probiotics and infant nutrition are among the fast-rising categories in China’s e-commerce space, according to two sector specialists featured in our latest Nutrition Asia video series.
Last week we revealed that the NutraIngredients’ teams worldwide were to host the first ever co-ordinated series of webinars looking at immunity, and now we can reveal the stellar line-up for the first APAC event which will focus on clinical research.
Cannabidiol (CBD) and tetrahydrocannabinol (THC) are increasingly gaining traction and are said to hold “great promise” for managing chronic pain, claims a leading Australian researcher who stars in our seventh NutraChampion podcast.
The Q1 financial reports of China’s nutraceutical and TCM firms have shown mixed results due to the COVID-19 pandemic, with TCM firm Yiling Pharma reaping more than 50% growth in profits, while that of BY-HEALTH had shrunk due to disruptions in retail...
In this round-up, we shine the spotlight on China's new cross-border e-commerce pilot zones and its implications for the supplement industry, India's task force to stem unsupported product claims against COVID-19, and more.
Diabetic patients who adopt a nutrition therapy consisting of whey protein and monounsaturated fatty acids (MUFA) have lower fasting blood glucose during the one-month long Ramadan fasting period, a clinical trial in Malaysia has shown.
A curcumin and artemisinin-based oral spray has been proposed as a treatment for COVID-19 patients and a clinical trial will be conducted, ASX-listed phytocannabinoid firm MGC Pharmaceuticals has revealed.
China’s addition of 46 cross-border e-commerce (CBEC) pilot zones will lead to the further influx of imported dietary supplements, with the healthy competition between local and imported goods helping to raise the bar for China’s domestic industry, according...
China’s import and exports of health foods for this year will remain the same as last year or even see a slight growth despite trade disruptions caused by COVID-19, the China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMPHIE)...
China is conducting clinical trials to assess the effectiveness and safety of combining traditional Chinese medicine (TCM) and conventional Western antiviral medicine in the treatment of patients with the novel coronavirus (COVID-19).
India’s three-week lockdown has affected the nutrition and health businesses on multiple fronts, most directly on the production, supply chain, and e-commerce delivery, companies including FMCG giant and ayurvedic medicine specialist Dabur have told us.